EUROFINS SCIENTIFIC (ERF.PA) Fundamental Analysis & Valuation

EPA:ERF • FR0014000MR3

Current stock price

66.9 EUR
+1.84 (+2.83%)
Last:

This ERF.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ERF.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ERF was profitable.
  • In the past year ERF had a positive cash flow from operations.
  • Each year in the past 5 years ERF has been profitable.
  • Each year in the past 5 years ERF had a positive operating cash flow.
ERF.PA Yearly Net Income VS EBIT VS OCF VS FCFERF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • With a Return On Assets value of 3.73%, ERF perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
  • With a Return On Equity value of 9.02%, ERF perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • ERF has a better Return On Invested Capital (6.74%) than 61.11% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ERF is significantly below the industry average of 13.93%.
  • The last Return On Invested Capital (6.74%) for ERF is above the 3 year average (6.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROIC 6.74%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ERF.PA Yearly ROA, ROE, ROICERF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a Profit Margin value of 5.62%, ERF is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
  • ERF's Profit Margin has declined in the last couple of years.
  • ERF's Operating Margin of 10.87% is on the low side compared to the rest of the industry. ERF is outperformed by 72.22% of its industry peers.
  • In the last couple of years the Operating Margin of ERF has declined.
  • ERF's Gross Margin of 21.39% is on the low side compared to the rest of the industry. ERF is outperformed by 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of ERF has declined.
Industry RankSector Rank
OM 10.87%
PM (TTM) 5.62%
GM 21.4%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
ERF.PA Yearly Profit, Operating, Gross MarginsERF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ERF.PA Health Analysis

2.1 Basic Checks

  • ERF has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ERF has less shares outstanding than it did 1 year ago.
  • ERF has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ERF is higher compared to a year ago.
ERF.PA Yearly Shares OutstandingERF.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ERF.PA Yearly Total Debt VS Total AssetsERF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • ERF has an Altman-Z score of 2.58. This is not the best score and indicates that ERF is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ERF (2.58) is comparable to the rest of the industry.
  • ERF has a debt to FCF ratio of 5.14. This is a neutral value as ERF would need 5.14 years to pay back of all of its debts.
  • ERF's Debt to FCF ratio of 5.14 is fine compared to the rest of the industry. ERF outperforms 72.22% of its industry peers.
  • ERF has a Debt/Equity ratio of 0.82. This is a neutral value indicating ERF is somewhat dependend on debt financing.
  • ERF has a worse Debt to Equity ratio (0.82) than 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 2.58
ROIC/WACC0.88
WACC7.69%
ERF.PA Yearly LT Debt VS Equity VS FCFERF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that ERF should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.09, ERF is in line with its industry, outperforming 44.44% of the companies in the same industry.
  • ERF has a Quick Ratio of 1.03. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ERF (1.03) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ERF.PA Yearly Current Assets VS Current LiabilitesERF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ERF.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.73% over the past year.
  • The Earnings Per Share has been decreasing by -3.09% on average over the past years.
  • ERF shows a small growth in Revenue. In the last year, the Revenue has grown by 4.96%.
  • ERF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.05% yearly.
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%

3.2 Future

  • ERF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.11% yearly.
  • ERF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.47% yearly.
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue Next Year4.44%
Revenue Next 2Y5.49%
Revenue Next 3Y5.78%
Revenue Next 5Y7.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ERF.PA Yearly Revenue VS EstimatesERF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ERF.PA Yearly EPS VS EstimatesERF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. ERF.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ERF is valuated rather expensively with a Price/Earnings ratio of 17.98.
  • 66.67% of the companies in the same industry are more expensive than ERF, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.17, ERF is valued a bit cheaper.
  • ERF is valuated rather expensively with a Price/Forward Earnings ratio of 17.15.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ERF indicates a somewhat cheap valuation: ERF is cheaper than 66.67% of the companies listed in the same industry.
  • ERF's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.05.
Industry RankSector Rank
PE 17.98
Fwd PE 17.15
ERF.PA Price Earnings VS Forward Price EarningsERF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ERF is valued a bit cheaper than 77.78% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ERF indicates a rather cheap valuation: ERF is cheaper than 88.89% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.13
EV/EBITDA 10.44
ERF.PA Per share dataERF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ERF's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.16
PEG (5Y)N/A
EPS Next 2Y11.81%
EPS Next 3Y13.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ERF.PA Dividend Analysis

5.1 Amount

  • ERF has a Yearly Dividend Yield of 1.16%. Purely for dividend investing, there may be better candidates out there.
  • ERF's Dividend Yield is rather good when compared to the industry average which is at 0.45. ERF pays more dividend than 88.89% of the companies in the same industry.
  • ERF's Dividend Yield is slightly below the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.16%

5.2 History

  • On average, the dividend of ERF grows each year by 16.09%, which is quite nice.
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
ERF.PA Yearly Dividends per shareERF.PA Yearly Dividends per shareYearly Dividends per share 2018 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 26.80% of the earnings are spent on dividend by ERF. This is a low number and sustainable payout ratio.
  • The dividend of ERF is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP26.8%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
ERF.PA Yearly Income VS Free CF VS DividendERF.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ERF.PA Dividend Payout.ERF.PA Dividend Payout, showing the Payout Ratio.ERF.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ERF.PA Fundamentals: All Metrics, Ratios and Statistics

EUROFINS SCIENTIFIC

EPA:ERF (4/2/2026, 7:00:00 PM)

66.9

+1.84 (+2.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners33.9%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.19B
Revenue(TTM)7.30B
Net Income(TTM)409.70M
Analysts72
Price Target72.41 (8.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.16%
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE 17.98
Fwd PE 17.15
P/S 1.67
P/FCF 14.13
P/OCF 8.71
P/B 2.68
P/tB N/A
EV/EBITDA 10.44
EPS(TTM)3.72
EY5.56%
EPS(NY)3.9
Fwd EY5.83%
FCF(TTM)4.73
FCFY7.08%
OCF(TTM)7.68
OCFY11.48%
SpS40.05
BVpS24.94
TBVpS-4.41
PEG (NY)2.16
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROCE 9.27%
ROIC 6.74%
ROICexc 7.43%
ROICexgc 23.86%
OM 10.87%
PM (TTM) 5.62%
GM 21.4%
FCFM 11.82%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ROICexc(3y)7.17%
ROICexc(5y)9.25%
ROICexgc(3y)23.01%
ROICexgc(5y)30.49%
ROCE(3y)8.97%
ROCE(5y)11.81%
ROICexgc growth 3Y-10.94%
ROICexgc growth 5Y-13.82%
ROICexc growth 3Y-8.95%
ROICexc growth 5Y-10.36%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 2.44
Cap/Depr 74.23%
Cap/Sales 7.35%
Interest Coverage 6.87
Cash Conversion 92.26%
Profit Quality 210.5%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 2.58
F-Score7
WACC7.69%
ROIC/WACC0.88
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.15%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year4.44%
Revenue Next 2Y5.49%
Revenue Next 3Y5.78%
Revenue Next 5Y7.47%
EBIT growth 1Y-4.65%
EBIT growth 3Y-8.54%
EBIT growth 5Y-4.97%
EBIT Next Year81.37%
EBIT Next 3Y28.68%
EBIT Next 5Y24.78%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%

EUROFINS SCIENTIFIC / ERF.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.


What is the valuation status for ERF stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.


What is the profitability of ERF stock?

EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for ERF stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ERF.PA) is 17.98 and the Price/Book (PB) ratio is 2.68.


What is the financial health of EUROFINS SCIENTIFIC (ERF.PA) stock?

The financial health rating of EUROFINS SCIENTIFIC (ERF.PA) is 4 / 10.